Clinical trial
Multimodal Risk Factor Graph Mapping, Metabolic Subtyping, and Digital Intelligent Chronic Disease Management for Prediabetes: An Integrated Cohort and Case-Control Clinical Study
NCT07854002 is registered in ClinicalTrials.gov with Nanjing Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multimodal Risk Factor Graph Mapping, Metabolic Subtyping, and Digital Intelligent Chronic Disease Management for Prediabetes: An Integrated Cohort and Case-Control Clinical Study
- Lead sponsor
- Nanjing Medical University
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- October 8, 2026
- Completion date
- August 31, 2029
- Enrollment
- 30,000 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
impaired fasting glucose, impaired glucose tolerance (prediabetes), prediabetes, prediabetes (insulin resistance, impaired glucose tolerance)